Hospitalized patients with opioid use disorder who received higher doses of short-acting opioids were less likely to leave the hospital within 72 hours, according to a study published June 16 in JAMA Network Open. Researchers from the University of California…
Addiction Treatment
The FDA on June 16 approved Rextovy, a 4-milligram naloxone hydrochloride nasal spray, for over-the-counter use. The decision aligns with President Donald Trump’s federally coordinated effort to address the addiction and substance use crisis across the U.S., according to a…
Kratom-related exposure reports to poison-control centers increased by more than 1,200% between 2015 and 2025, according to a 2026 study published in the CDC’s “Morbidity and Mortality Weekly Report.” The drug is derived from a tropical tree native to Southeast…
When one in six Americans over age 12 experiences substance use disorders, it’s understandable to look to GLP-1s, a medication that quells desire, as a possible treatment. That’s especially true in light of study results making headlines, the fact that there only are few…
A Philadelphia-based Penn Medicine intervention increased the likelihood that emergency department patients with alcohol use disorder would receive naltrexone prescriptions by 15-fold, according to a study published in the Annals of Emergency Medicine. Researchers from the Perelman School of Medicine…
Advertisement
The Elevance Health Public Policy Institute found no association between county-level uptake of take-home methadone — used to treat opioid use disorder — and differences in drug overdose rates and behavioral health- or OUD-related emergency department visits. Published May 25…
Lebanon, N.H.-based Dartmouth Health’s Dartmouth Hitchcock Medical Center is launching a dedicated inpatient program for pregnant patients with substance use disorders, with plans to double patient capacity within the program’s first year. The health system said the program is the…
West Orange, N.J.-based RWJBarnabas is expanding its hospital-based naloxone distribution initiative statewide through its Institute for Prevention and Recovery, with the goal of distributing more than 15,000 naloxone kits and wellness bags across New Jersey. The initiative will distribute kits…
For the third consecutive year, U.S. drug overdose deaths have fallen, marking the longest sustained drop in decades. But addiction leaders warn the gains remain fragile. Itai Danovitch, MD, chair of the department of psychiatry and behavioral neurosciences at Los…
Spokane, Wash.-based MultiCare Deaconess Hospital has administered a long-acting buprenorphine 19 times since launching a pilot program in February 2025 aimed at treating patients experiencing opioid overdose or withdrawal. The injectable medication provides up to five days of symptom relief…